cdn mobile

Lawyers, doctors preparing cases vs Duque over Dengvaxia mess

By: Inquirer.net August 30,2018 - 08:54 PM

PUBLIC Attorneys’ Office (PAO) forensics chief Dr. Erwin Erfe revealed yesterday that lawyers and doctors are preparing cases against Health Secretary Francisco Duque III to revoke his license as a doctor in connection with the alleged deaths of children due to the controversial Dengvaxia anti-dengue vaccine.

Erfe said these groups are also planning to bring the cases to the International Criminal Court (ICC).

“There were groups of doctors and lawyers planning to file cases against Secretary Duque to have his license as a doctor revoked by the Professional Regulation Commission and bring the cases to the International Criminal Court,” Erfe said in Filipino in a press conference.

“These cases are now being prepared by the lawyers and doctors against Secretary Duque,” he added, though he refused to disclose the identities of the lawyers and doctors.

Earlier, PAO included Duque in its complaints for reckless imprudence resulting in homicide and for violation of the Anti-Torture Law filed before the Department of Justice.

Former Health secretary Janette Garin, officials of Sanofi Pasteur, Dengvaxia distributor Zuellig Pharma, and several other Department of Health officials were included in the complaint filed last April.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: cases, Dengvaxia, doctors, Duque, lawyers, mess
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.